Spero Therapeutics and Innovent Biologics Announce Exclusive License for SP001 (IBI355), a Phase 2-Ready Third-Generation Anti-CD40L Antibody

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. EAT

Go back to Spero Therapeutics and Innovent Biologics Announce Exclusive License for SP001 (IBI355), a Phase 2-Ready Third-Generation Anti-CD40L Antibody
SmartPros Ltd. (NASDAQ: SPRO) Delayed: 1.21 -0.01 (0.82%)
Previous Close $1.22    52 Week High $3.85 
Open $1.20    52 Week Low $1.25 
Day High $1.22    P/E N/A 
Day Low $1.19    EPS $-0.28 
Volume 362,984